These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21847598)

  • 21. In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis.
    Morais-Teixeira Ed; Carvalho AS; Costa JC; Duarte SL; Mendonça JS; Boechat N; Rabello A
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):358-62. PubMed ID: 18660990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
    Carrió J; Portús M
    BMC Pharmacol; 2002 May; 2():11. PubMed ID: 12019027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel Niosomal Combination of Selenium Coupled with Glucantime against Leishmania tropica.
    Mostafavi M; Khazaeli P; Sharifi I; Farajzadeh S; Sharifi H; Keyhani A; Parizi MH; Kakooei S
    Korean J Parasitol; 2019 Feb; 57(1):1-8. PubMed ID: 30840792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensis.
    Peixoto JF; Gonçalves-Oliveira LF; Souza-Silva F; de Castro Côrtes LM; Finkelstein LC; Dias-Lopes G; Patricio BFC; Lima CGS; Rocha HVA; da Silva FC; Ferreira VF; Pereira BAS; Alves CR
    Int J Parasitol Drugs Drug Resist; 2024 Apr; 24():100525. PubMed ID: 38359731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of thiol metabolism in resistance to glucantime in Leishmania tropica.
    Arana FE; Pérez-Victoria JM; Repetto Y; Morello A; Castanys S; Gamarro F
    Biochem Pharmacol; 1998 Nov; 56(9):1201-8. PubMed ID: 9802332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antileishmanial effect of rapamycin as an alternative approach to control Leishmania tropica infection.
    Khadir F; Taheri T; Habibzadeh S; Zahedifard F; Gholami E; Heidari-Kharaji M; Oryan A; Rafati S
    Vet Parasitol; 2019 Dec; 276():108976. PubMed ID: 31739256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake and antileishmanial activity of meglumine antimoniate-containing liposomes in Leishmania (Leishmania) major-infected macrophages.
    Borborema SE; Schwendener RA; Osso JA; de Andrade HF; do Nascimento N
    Int J Antimicrob Agents; 2011 Oct; 38(4):341-7. PubMed ID: 21783345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.
    Carrió J; de Colmenares M; Riera C; Gállego M; Arboix M; Portús M
    Exp Parasitol; 2000 Jul; 95(3):209-14. PubMed ID: 10964649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural resistance to meglumine antimoniate is associated with treatment failure in cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis.
    Fernández OL; Rosales-Chilama M; Sánchez-Hidalgo A; Gómez P; Rebellón-Sánchez DE; Regli IB; Díaz-Varela M; Tacchini-Cottier F; Saravia NG
    PLoS Negl Trop Dis; 2024 May; 18(5):e0012156. PubMed ID: 38709850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
    Moosavian SA; Fallah M; Jaafari MR
    Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro.
    Néris PL; Caldas JP; Rodrigues YK; Amorim FM; Leite JA; Rodrigues-Mascarenhas S; Barbosa-Filho JM; Rodrigues LC; Oliveira MR
    Exp Parasitol; 2013 Oct; 135(2):307-13. PubMed ID: 23891943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a Possible Synergistic Effect of Meglumine Antimoniate with Paromomycin, Miltefosine or Allopurinol on in Vitro Susceptibility of Leishmania tropica Resistant Isolate.
    Rezaei Riabi T; Sharifi I; Miramin Mohammadi A; Khamesipour A; Hakimi Parizi M
    Iran J Parasitol; 2013 Jul; 8(3):396-401. PubMed ID: 24454432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sinergism between alkaloids piperine and capsaicin with meglumine antimoniate against Leishmania infantum.
    Vieira-Araújo FM; Macedo Rondon FC; Pinto Vieira ÍG; Pereira Mendes FN; Carneiro de Freitas JC; Maia de Morais S
    Exp Parasitol; 2018 May; 188():79-82. PubMed ID: 29625099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of hydroxyurea against Leishmania mexicana.
    Martinez-Rojano H; Mancilla-Ramirez J; Quiñonez-Diaz L; Galindo-Sevilla N
    Antimicrob Agents Chemother; 2008 Oct; 52(10):3642-7. PubMed ID: 18694950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stachys lavandulifolia Vahl. exhibits promising in vitro and in vivo antileishmanial activity against Leishmania major infection.
    Alanazi AD; Albalawi AE; Almohammed HI; Shater AF
    Trop Biomed; 2022 Sep; 39(3):412-420. PubMed ID: 36214438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum.
    Adinehbeigi K; Razi Jalali MH; Shahriari A; Bahrami S
    Pathog Glob Health; 2017 Jun; 111(4):176-185. PubMed ID: 28385129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of topical liposomes containing meglumine antimoniate (Glucantime) for the treatment of L. major lesion in BALB/c mice.
    Kalat SA; Khamesipour A; Bavarsad N; Fallah M; Khashayarmanesh Z; Feizi E; Neghabi K; Abbasi A; Jaafari MR
    Exp Parasitol; 2014 Aug; 143():5-10. PubMed ID: 24780938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel approach to in vitro drug susceptibility assessment of clinical strains of Leishmania spp.
    Fernández O; Diaz-Toro Y; Valderrama L; Ovalle C; Valderrama M; Castillo H; Perez M; Saravia NG
    J Clin Microbiol; 2012 Jul; 50(7):2207-11. PubMed ID: 22518860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The leishmanicidal effect of Lucilia sericata larval saliva and hemolymph on in vitro Leishmania tropica.
    Rahimi S; Khamesipour A; Akhavan AA; Rafinejad J; Ahmadkhaniha R; Bakhtiyari M; Veysi A; Akbarzadeh K
    Parasit Vectors; 2021 Jan; 14(1):40. PubMed ID: 33430900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of antimony resistance markers in Leishmania tropica field isolates through a cDNA-AFLP approach.
    Kazemi-Rad E; Mohebali M; Khadem-Erfan MB; Saffari M; Raoofian R; Hajjaran H; Hadighi R; Khamesipour A; Rezaie S; Abedkhojasteh H; Heidari M
    Exp Parasitol; 2013 Oct; 135(2):344-9. PubMed ID: 23928349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.